expert reaction to reprogramming brain cells for Parkinson’s
In a new study publishing in Nature Biotechnology researchers describe how they reprogrammed human astrocytes in vitro, and mouse astrocytes in vivo, into induced dopamine neurons.
Prof. David Dexter, Deputy Director of Research, Parkinson’s UK, said:
“This is a very robust study where the authors have provided good evidence of being able to turn astrocytes into cells that resemble dopamine neurons both in cultured cells and directly in the brains of an animal model of Parkinson’s.
